Livermore

Curative Ventures V LLC

SEC CIK
0001754072

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Jul 31, 2026.SEC

Positions
1
0 vs. Q1 2026
Total value
$14.6M
−$1.04M (−6.7%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

Curative Ventures V LLC holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
TILINSTIL BIO INCCOM1,899,004$14.6M100.00%00.0%UnchangedView

13F filings by quarter

Curative Ventures V LLC 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Jul 31, 20261$14.6Mvs. Q1 2026SEC
Q1 2026Apr 29, 20261$15.65Mvs. Q4 2025SEC
Q4 2025Feb 3, 20261$20.89Mvs. Q3 2025SEC
Q3 2025Nov 3, 20251$33.92Mvs. Q2 2025SEC
Q2 2025Jul 29, 20251$39.56Mvs. Q1 2025SEC
Q1 2025Apr 30, 20251$32.97Mvs. Q4 2024SEC
Q4 2024Jan 29, 20251$36.25Mvs. Q3 2024SEC
Q3 2024Oct 31, 20241$127.84Mvs. Q2 2024SEC
Q2 2024Jul 17, 20241$19.54Mvs. Q1 2024SEC
Q1 2024May 8, 20241$20.51Mvs. Q4 2023SEC
Q4 2023Feb 12, 20241$14.47Mvs. Q3 2023SEC
Q3 2023Nov 13, 20231$16.26Mvs. Q2 2023SEC
Q2 2023Aug 2, 20231$20.93Mvs. Q1 2023SEC
Q1 2023May 8, 20231$25.1Mvs. Q4 2022SEC
Q4 2022Jan 30, 20231$23.93Mvs. Q3 2022SEC
Q3 2022Nov 10, 20221$183.82Mvs. Q2 2022SEC
Q2 2022Aug 4, 20221$175.47Mvs. Q1 2022SEC
Q1 2022May 13, 20221$408.29Mvs. Q4 2021SEC
Q4 2021Feb 14, 20221$649.84M–SEC